Paradigm Biocapital Advisors »

Genmab A/s -sp shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Genmab A/s -sp (GMAB) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Genmab A/s -sp

Tip: Access up to 7 years of quarterly data

All positions including Genmab A/s -sp held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genmab A/s -sp by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $117M 3.8M 30.67

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Merus N V Call Option (MRUS)
Arcellx Common Stock (ACLX)
Revolution Medicines (RVMD)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Abivax Sa Sponsored Ads (ABVX)
Genmab A/s Sponsored Ads (GMAB)
Agios Pharmaceuticals Call Option (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Spdr Series Trust S&p Biotech Put Option (XBI)
Edgewise Therapeutics (EWTX)
Cidara Therapeutics Com New (CDTX)
Urogen Pharma (URGN)
Scholar Rock Hldg Corp (SRRK)

View all positions for Paradigm Biocapital Advisors

Top funds holding Genmab A/s -sp

Orbis Allan Gray
Alliancebernstein
Paradigm Biocapital Advisors
Arrowstreet Capital, Limited Partnership
Harding Loevner
BlackRock
Renaissance Technologies
Morgan Stanley
First Trust Advisors
Two Sigma Advisers
Brandywine Global Investment Management
Two Sigma Investments
FMR
Goldman Sachs Group
Northern Trust

View all funds holding Genmab A/s -sp